BIT
Click for more information
0.00% 2.2¢ biotron limited

Ann: Letter to Shareholders, page-191

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. elephantsong
    499 Posts.
    lightbulb Created with Sketch. 273
    clock Created with Sketch.
    12/07/19
    15:31
    Post #: 39497570


    The whole basis of HIV human immunodeficiency viruses (HIV) as the name suggests... is it degrades the human immune system.
    The immune system becomes exhausted in HIV patients.

    So that point about Immune System recovery for HIV patients as a result of BIT225 treatment in addition to ART ...IS VERY SIGNIFICANT!
    Also, The result was in a human trial ...not a test tube.

    FDA ... here we come.


    BIT Price at posting: 8.3¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 13  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Scoping study unveils promising economics for the Ngami Copper Project, with potential copper resources up to 166Mt — find out more about what makes this a game-changer
right-arrow Created with Sketch.
NVU Nanoveu commences crucial benchmark testing for System-on-aChip (SoC) Semiconductor technology
right-arrow Created with Sketch.
NEWS Canyon-1H well drilling advancing as planned, with promising results observed and key milestones on track for completion by late October
right-arrow Created with Sketch.
NEWS MOU executed with leading maritime partner to advance plans for a multi-user transhipping facility in West Pilbara
right-arrow Created with Sketch.
NEWS Form 20-F filed to explore U.S. market opportunities through proposed Nasdaq ADS listing, aligning with strategic global growth goals
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $19.85M
Open High Low Value Volume
2.2¢ 2.3¢ 2.2¢ $8.562K 389.1K

Buyers (Bids)

No. Vol. Price($)
1 228 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 1991719 1
View Market Depth
Last trade - 14.47pm 18/10/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.